![](/images/general/no_picture/200_user.png)
Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12680875
[patent_doc_number] => 20180118791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => MODIFIED LANTIBIOTICS AND METHODS OF MAKING AND USING THE MODIFIED LANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 15/797001
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15797001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/797001 | Modified lantibiotics and methods of making and using the modified lantibiotics | Oct 29, 2017 | Issued |
Array
(
[id] => 12621576
[patent_doc_number] => 20180099022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => NOVEL POLYMYXIN DERIVED CELL PENETRATING SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 15/727397
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727397
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/727397 | Polymyxin derived cell penetrating scaffolds | Oct 5, 2017 | Issued |
Array
(
[id] => 16680777
[patent_doc_number] => 10940233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Fibrinogen composition, method and wound articles
[patent_app_type] => utility
[patent_app_number] => 16/338803
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 11
[patent_no_of_words] => 14641
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338803 | Fibrinogen composition, method and wound articles | Oct 3, 2017 | Issued |
Array
(
[id] => 14864853
[patent_doc_number] => 20190282668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PTH Compounds with Low Peak-To-Trough Ratios
[patent_app_type] => utility
[patent_app_number] => 16/337955
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337955 | PTH compounds with low peak-to-trough ratios | Sep 27, 2017 | Issued |
Array
(
[id] => 12585630
[patent_doc_number] => 20180087039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => TISSUE FACTOR (TF)-TARGETED NANOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/715977
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715977
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/715977 | Tissue factor (TF)--targeted nanotherapy | Sep 25, 2017 | Issued |
Array
(
[id] => 16405439
[patent_doc_number] => 10813976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => Ophthalmic compositions comprising ciclosporin
[patent_app_type] => utility
[patent_app_number] => 16/336005
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5577
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336005
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336005 | Ophthalmic compositions comprising ciclosporin | Sep 21, 2017 | Issued |
Array
(
[id] => 15035655
[patent_doc_number] => 20190328832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => ANTIMICROBIAL COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 16/334003
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334003 | ANTIMICROBIAL COMBINATIONS | Sep 17, 2017 | Abandoned |
Array
(
[id] => 14609787
[patent_doc_number] => 10357572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Prodrugs activated by caspase
[patent_app_type] => utility
[patent_app_number] => 15/690157
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 9235
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15690157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/690157 | Prodrugs activated by caspase | Aug 28, 2017 | Issued |
Array
(
[id] => 12117303
[patent_doc_number] => 20180000889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/688314
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 70260
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688314
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688314 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 12117304
[patent_doc_number] => 20180000890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/688326
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 70259
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688326 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 12137060
[patent_doc_number] => 20180015140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/688338
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 70320
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688338 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 13699847
[patent_doc_number] => 20170360878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
[patent_app_type] => utility
[patent_app_number] => 15/688336
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688336 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 13687507
[patent_doc_number] => 20170354708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
[patent_app_type] => utility
[patent_app_number] => 15/688341
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688341 | PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS | Aug 27, 2017 | Abandoned |
Array
(
[id] => 12117302
[patent_doc_number] => 20180000888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/688305
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 70260
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688305 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 13699843
[patent_doc_number] => 20170360876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
[patent_app_type] => utility
[patent_app_number] => 15/688322
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688322
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688322 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 13699845
[patent_doc_number] => 20170360877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
[patent_app_type] => utility
[patent_app_number] => 15/688330
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688330
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688330 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 12486747
[patent_doc_number] => 09993520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Vasopressin formulations for use in treatment of hypotension
[patent_app_type] => utility
[patent_app_number] => 15/688334
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 59478
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688334 | Vasopressin formulations for use in treatment of hypotension | Aug 27, 2017 | Issued |
Array
(
[id] => 17134822
[patent_doc_number] => 11136368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Cancer treatment using CX26 blocking peptides
[patent_app_type] => utility
[patent_app_number] => 16/326741
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 14089
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326741 | Cancer treatment using CX26 blocking peptides | Aug 22, 2017 | Issued |
Array
(
[id] => 14501247
[patent_doc_number] => 20190194278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => NOVEL IMMUNOSTIMULATING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/327135
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327135 | Immunostimulating peptides | Aug 22, 2017 | Issued |
Array
(
[id] => 15978001
[patent_doc_number] => 10669309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Method for extracting epsilon-polylysine and its hydrochloride salt from fermentation broth
[patent_app_type] => utility
[patent_app_number] => 15/677023
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4384
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677023
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677023 | Method for extracting epsilon-polylysine and its hydrochloride salt from fermentation broth | Aug 14, 2017 | Issued |